Chronic constipation (CIC)

Infrequent or difficult stools as a bowel disorder in its own right. Rome V uses chronic constipation, not “functional constipation”. Not the same as IBS-C. Community experiences, not medical advice.

Community experiences, not medical advice
Established Evidence

What is chronic constipation (CIC)?

Chronic constipation means difficult, infrequent, or incomplete bowel movements that persist, without a single obvious disease to explain them after appropriate checks. Older papers call this chronic idiopathic constipation (CIC) or Rome IV “functional constipation”. Rome V (2026) drops “functional constipation” and uses chronic constipation. Rome IV criteria were published in 2016.

NHS information describes constipation as going less often than is usual for you, passing hard stools, or straining. What counts as “chronic” is a clinical judgement using duration and symptom pattern, not a self-label from a quiz. Guts UK notes that going from three times a day to three times a week can still be a normal range — it is change, difficulty, or hard stools that usually matter more than a stopwatch.

How CIC differs from IBS-C, STC, and dyssynergia

  • IBS-C — a Rome IBS subtype: recurrent abdominal pain or discomfort (Rome V, 2026; Rome IV in 2016 required pain) related to defecation and a change in stool, with constipation-predominant stools. CIC is not IBS-C. You can have constipation without meeting IBS criteria.
  • Slow-transit constipation (STC) — a physiological finding: the colon moves contents slowly. Some people with CIC have slow transit; others do not. STC is a mechanism, not another name for CIC.
  • Dyssynergic defecation — an outlet problem. The pelvic floor or anal sphincter does not relax or coordinate when you try to pass stool. Biofeedback-oriented assessment is a different path from “take a stronger laxative”.

These can overlap. Distinguishing them is the clinician’s job. This page does not equate CIC with IBS-C.

Common symptoms

  • Infrequent stools
  • Hard or lumpy stools
  • Straining, or a sense of blockage or incomplete emptying
  • Bloating for some people

New constipation, blood, weight loss, or a sudden change in bowel habit needs medical review rather than a website plan.

Approaches people discuss

Constipation care is stepped. Prescription motility medicines are not a starter pack.

  • Established First steps the NHS already names: fluid, activity, and fibre changes that a GP or dietitian can individualise. Not a colon cleanse. Sources: NHS constipation; NICE CKS; Guts UK.
  • Established Laxatives in classes recommended in NICE CKS (for example bulk-forming, osmotic, then stimulant), stepped and reviewed. AGA–ACG 2023 also starts with fibre, osmotic laxatives, and stimulant laxatives before prescription motility medicines — that supports the same order, not a US brand to buy. Sources: NICE CKS; Chang et al. 2023 PMID 37211380.
  • Emerging Specialist tests (transit studies, anorectal physiology) when first-line care fails — to look for slow-transit constipation or dyssynergia. Sources: NICE CKS; see also slow-transit constipation, dyssynergic defecation, and pelvic floor dysfunction.
  • Limited Prucalopride is not first-line. NICE TA211 recommends prucalopride for women with chronic constipation after at least two laxative classes at the highest tolerated doses for 6 months, with a review at 4 weeks. The UK marketing licence was later widened to adults; the TA text is still written as women-only. It is not a starter medicine for ordinary constipation. AGA–ACG 2023 recommends prucalopride for adults with chronic idiopathic constipation who have not responded to over-the-counter laxatives. Sources: NICE TA211; Chang et al. 2023 PMID 37211380.

Colon cleanses, herbal "resets", and coffee enemas are not a treatment for CIC. They are not in NHS or NICE pathways and can do harm.

Community insights

Anecdotal themes:

  • People compare notes on how often they go. Guts UK’s 3-times-a-day to 3-times-a-week range is the community reminder that “normal” is wide.
  • People are often given an IBS-C label when pain is not the main story — or the reverse.
  • Rotating the same stimulant without a plan is a common frustration; NICE pathways expect review, not endless escalation at home.
  • Pelvic-floor physiotherapy comes up when straining and incomplete emptying dominate — that points toward dyssynergia, not a cleanse.
  • Online “detox” offers are widely shared and widely regretted in community threads.

Guidelines and sources

UK sources on this page are NHS, Guts UK, NICE CKS and NICE TA211. Rome V is the international criteria set; AGA–ACG 2023 sits behind the stepped-laxative and not-first-line prucalopride points already here.

NHS — constipation

NHS advice on constipation, lifestyle measures, and when to see a GP.

Visit Resource

Guts UK — constipation

Charity information, including that going three times a day to three times a week can still be a normal range.

Visit Resource

NICE CKS — constipation

Primary-care pathway, including laxatives before specialist drugs.

Visit Resource

NICE TA211 — prucalopride

Original TA: women after ≥2 laxative classes for 6 months, review at 4 weeks. UK licence later widened to adults; TA text remains women-only. Not first-line.

Visit Resource

Rome Foundation — Rome V

Rome V (2026) replaces the term functional constipation with chronic constipation. Rome IV was 2016.

Visit Resource

BSG

British Society of Gastroenterology guidance relevant to chronic diarrhoea and constipation pathways in secondary care.

Visit Resource

Rome V — bowel disorders

The 2026 Rome V bowel-disorders chapter is the journal source for dropping "functional constipation" and using chronic constipation, while keeping IBS-C as a separate bowel disorder grouped by pain or discomfort plus stool pattern. That is the paper behind the Rome V wording already on this page, not a new quiz and not a reason to treat CIC as IBS-C.

PubMed PMID 41713703

AGA–ACG 2023 — chronic idiopathic constipation

A 2023 joint American Gastroenterological Association–American College of Gastroenterology guideline on chronic idiopathic constipation also starts with fibre, osmotic laxatives, and stimulant laxatives before prescription motility medicines. It recommends prucalopride for adults with CIC who do not respond to over-the-counter agents — the US twin of the NICE CKS order and the "not first-line" point already here.

PubMed PMID 37211380

Medical disclaimer

Community experiences, not medical advice. This page is for education only. It is not a diagnosis, treatment plan, or substitute for care from a qualified clinician. Always discuss tests, medicines, and diet changes with your GP or specialist.